Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma

Table 1

The combinations and frequencies of MMP-2 and TIMP-2 subgroups among endometrioid adenocarcinoma patients (𝑛=225).

Immunostaining	Frequency	Percent
MMP-2− and TIMP-2+	6	2.7
MMP-2− and TIMP-2−	18	8.0
MMP-2+ and TIMP-2+	93	41.3
MMP-2+ and TIMP-2−	108	48.0
Total	225	100